Chinook Therapeutics Presents Updated Data from BION-1301
The initial response to de novo subcutaneous (SC) BION-1301 treatment in Cohort 2 is highly consistent with Cohort 1 across both mechanistic biomarkers and...
Source: globenewswire.com
Primary Hyperoxalurias News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Primary Hyperoxalurias. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.